Search – Page 219 – Indianapolis Business Journal

Home » Search

Articles

Braun administration, Eli Lilly to collaborate on nuclear power development

April 16, 2026 | Joey Harris

The Indianapolis-based pharmaceutical giant and the state’s Office of Energy Development signed a nonbinding letter of intent to explore the potential deployment of small modular reactors.

What is ‘Ozempic personality’ and why does it make life feel ‘meh’?

April 17, 2026 | The Washington Post

The new class of GLP-1 drugs are generally considered safe. Their metabolic effects have been scrutinized in studies, but their psychological impact is far less understood.

Ossium Health aims to revolutionize role of bone marrow banks

April 17, 2026 | Daniel Bradley

The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.

UPDATE: Eli Lilly acquiring Boston-based biotech in deal worth up to $7B

April 20, 2026 | IBJ Staff

Lilly has been bringing in record revenue from its weight-loss medicines, but continues to diversify its pipeline candidates through acquisitions of biotech companies that are developing new genetic therapies for cancer and other disorders.

IU, Zimmer Biomet forge 3-year partnership to advance orthopedic sector

April 20, 2026 | Daniel Bradley

The focus of the agreement is to meet the evolving needs of Indiana’s orthopedic sector, which represents one-third of the industry’s global workforce.

Insurers balk at Trump’s plan to cover obesity drugs in Medicare

April 21, 2026 | Bloomberg News

Health insurers are raising questions about the Trump administration’s plan to cover obesity drugs in Medicare next year.

Q&A: Cardiologist has spent career working on treatment for rare condition

April 22, 2026 | Daniel Bradley

Dr. Mark Payne, a professor of pediatrics at the Indiana University School of Medicine and a pediatric cardiologist at Riley Children’s Health, has been working on a treatment for a neurodegenerative condition called Friedreich’s ataxia for decades.

Central Indiana excelling in life sciences, but it needs a brand, speakers say

April 23, 2026 | Daniel Bradley

The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, according to speakers at IBJ’s Life Sciences Power Breakfast.

Complex process leads to a new drug’s identity

April 24, 2026 | Daniel Bradley

The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal analysis and regulatory compliance.

Defense firm V2X, analytics startup Ekkobar among 2026 Mira Award winners

April 24, 2026 | Susan Orr

TechPoint announced 17 awards Friday night at its Mira Awards gala in Carmel. The annual awards program recognizes achievements in Indiana’s tech sector.

Lilly acquiring cancer-drug firm Ajax Therapeutics in deal worth up to $2.3B

April 27, 2026 | Daniel Bradley

The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.

Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine

April 29, 2026 | Daniel Bradley

The Indianapolis-based drugmaker will partner with Profluent to develop and commercialize treatments for diseases with severe unmet needs.

Lilly earnings increase as Mounjaro, Zepbound sales continue rise

April 30, 2026 | Daniel Bradley

The Indianapolis-based drugmaker reported profit of $7.4 billion for the first quarter, up from $2.8 billion in the same period a year earlier.

Stocks rally to finish best month since 2020, even as oil prices whipsaw

April 30, 2026 | Associated Press

Alphabet led the way and rallied 10% after the owner of Google and YouTube reported profit for the latest quarter that almost doubled analysts’ expectations.

2026 Innovation Issue: Entrepreneur Richard DiMarchi stays locked in as the market for blockbuster drugs evolves

May 1, 2026 | Lesley Weidenbener and Tom Murphy / Special to IBJ

Richard DiMarchi still works a full schedule, researching and teaching at Indiana University.

2026 Innovation Issue: Two executives going all-in on AI

May 1, 2026 | Mickey Shuey

A real estate leader and pharmaceutical executive explain the practical and surprising ways they’re using AI in their fields and what the future might look like for AI and their industries..

2026 Innovation Issue: Great Indiana innovations

May 1, 2026 | Samm Quinn

In the first Innovation Issue in 2015, IBJ featured several Indiana innovations. We’re revisiting some of those and introducing a few more worth mentioning.

Nate Feltman: Building a bioscience powerhouse

May 1, 2026 | Nate Feltman

Central Indiana has a real opportunity not only to compete in the biosciences but to become the next great American hub on the scale of North Carolina’s Research Triangle.

Lilly announces additional $4.5B investment at LEAP District manufacturing site

May 6, 2026 | Daniel Bradley

Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.

Lilly looks to sell about $8B of debt to fund acquisitions

May 7, 2026 | Bloomberg News

The move comes as Lilly has embarked on a spree of large acquisitions, including two of its most-expensive transactions ever.

« Previous 1 … 217 218 219 220 221 Next »

Search Results

4,410 results for '\"eli lilly\"'